Tenecteplase versus alteplase in stroke thrombolysis: An individual patient data meta-analysis of randomized controlled trials
Xuya Huang, Rachael MacIsaac, John LP Thompson, Bruce Levin, Richard Buchsbaum, E Clarke Haley, Christopher Levi, Bruce Campbell, Christopher Bladin, Mark Parsons, Keith W Muir
International Journal of Stroke | SAGE PUBLICATIONS LTD | Published : 2016
Awarded by National Institute of Neurological Disorders and Stroke-National Institutes of Health
Awarded by Stroke Association
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Haley et al. was supported by grants (R01-NS37666 and R01-NS45170) from the National Institute of Neurological Disorders and Stroke-National Institutes of Health. Genentech, Inc. supplied study drug (both tenecteplase and alteplase) for this clinical trial but no other financial or other support. Parsons et al. was supported by a grant from the Australian National Health and Medical Research Council. ATTEST was funded by the Stroke Association (TSA 2010/04).